Lacibloc Dosage & Drug Information

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Special Precautions Adverse Reactions Drug Interactions Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Concise Prescribing Info

Contents

Lacidipine

Indications/Uses

Treatment of essential or primary HTN.

Click to view Lacibloc detailed prescribing information

Dosage/Direction for Use

Initially 2 mg daily, may be increased to 4 mg daily after 3-4 wk & if necessary to 6 mg daily.

Click to view Lacibloc detailed prescribing information

Administration

May be taken with or without food: Avoid grapefruit juice.

Special Precautions

Patients w/ hypotension, poor cardiac reserve, heart failure. Not to be used in cardiogenic shock, MI, acute unstable angina, chronic stable angina. May increase risk of developing heart failure in severe aortic stenosis. Sudden w/drawal may exacerbate angina. Hepatic impairment.

Click to view Lacibloc detailed prescribing information

Adverse Reactions

Dizziness, flushing, headache, hypotension, peripheral edema, tachycardia & palpitations. Nausea, other GI disturbances, increased micturition frequency, lethargy, eye pain & mental depression. Ischaemic chest pain; potential cerebral or myocardial ischemia or transient blindness.

Click to view Lacibloc detailed prescribing information

Drug Interactions

May enhance effects of β-blockers. Enhanced antihypertensive effects w/ aldesleukin & antipsychotics. May modify insulin & glucose responses. Interactions may occur w/ quinidine; carbamazepine, phenytoin, rifampicin; cimetidine & erythromycin.

Click to view Lacibloc detailed prescribing information

Storage

View Lacibloc storage conditions for details to ensure optimal shelf-life.

Description

View Lacibloc description for details of the chemical structure and excipients (inactive components).

Action

View Lacibloc mechanism of action for pharmacodynamics and pharmacokinetics details.

MIMS Class

Calcium Antagonists

ATC Classification

C08CA09 - lacidipine ; Belongs to the class of dihydropyridine derivative selective calcium-channel blockers with mainly vascular effects. Used in the treatment of cardiovascular diseases.

Regulatory Classification

Presentation/Packing

Form

Lacibloc FC tab 4 mg

Packing/Price

30's (P761/box)

Form

Lacibloc FC tab 6 mg

Packing/Price

24's (P647/box)

Lacibloc

lacidipine

Manufacturer:

Ultramed

Distributor:

Ultramed